Activity value 81bulgaria Buyer&Supplier,Last transaction date:
2026-03-29
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for huvepharma eood from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 118 transactions, with a transaction quantity of 826140.01 and a transaction weight of 685878.
Product description
Yumamycin 1 2 pallets, 100 bags, 2500 kg net wt, 2590 kg gross wt Sacox 120 microGranulate 5 pallets, 250 bags, 6250 kg net wt, 6475 kg gross wt Hostazym X 15000 microgranulated 4 pallets, 200 bags, 4000 kg net wt, 4180 kg gross wt Flavomycin 10 5 pallets, 250 bags, 5000 kg net wt, 5225 kg gross wt Hostazym X 60000 2 pallets, 100 bags, 2500 kg net wt, 2590 kg gross wt TOTAL 18 pallets, 900 bags, 20250 kg net wt, 21060 kg gross wt
Expand
huvepharma eood is bulgaria Buyer&Supplier,
and primarily engages in the import and export business of products such as additives,gin,nima.
According to the 52wmb.com global trade database, as of 2026-03-29, the company has completed 11209 international trades,
with its main trading regions covering russia,india,mexico etc.
The core products include HS23099090,HS3004200002,HS23099099 etc,
often transported via thessaloniki,port piraeus, port varna etc,
and its main trading partners are ооо ткф корпас,huvepharma sea pune pvt ltd.,ооо симбио.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on huvepharma eood is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.